AdaptX – a self-serve clinical management solution company – recently announced the completion of $10 million in funding led by Cercano Management and including Memorial Hermann Health System and Morningside Ventures, and returning investors Founders’ Co-op, Fortson VC, Star Equity, and WRF Capital. And AdaptX will use these new funds to support its rapid growth and to invest in its AI-driven Adaptive Clinical Management technology.
The company’s self-serve solutions empower clinical leaders to assess, improve, and manage care across patients using data from their electronic medical records (EMRs). And with AdaptX, clinicians rapidly adapt treatments and workflows, improving patient care while delivering immediate return on investment (ROI) for their institutions.
KEY QUOTES:
“At Memorial Hermann, we are committed to continuously improving care for patients across our community. AdaptX transforms clinical management by empowering clinical leaders to continuously assess, improve, and manage care with their own real-world data. We are excited not only to invest in AdaptX but also to use their solutions to enhance our care capacity and quality.”
— Feby Abraham, PhD, executive vice president and chief strategy officer for Memorial Hermann Health System
“AdaptX has achieved tremendous growth across the health system market. We are excited to deepen our support of AdaptX as it deploys its self-serve clinical management solutions across acute and ambulatory care environments in the U.S. and internationally.”
— YB Choi, partner at Cercano Management
“Healthcare leaders are using AdaptX to deliver solutions for their greatest challenges: increasing capacity and access, improving quality, enhancing equity, reducing burnout, and reducing greenhouse emissions. AdaptX has proven that our solutions catalyze dramatic improvements for any health system, from large-scale academic environments to much smaller rural communities.”
— Dan Low, MD, chief medical officer of AdaptX
“We are thrilled with the fantastic support of our new and returning investors. It is a testament to the incredible work of AdaptX’s team that our fundraising round was oversubscribed despite the challenging economic environment.”
— Warren Ratliff, chief executive officer of AdaptX
